Document Detail

Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatide.
MedLine Citation:
PMID:  15593198     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The association between vertebral fracture severity and health-related quality of life (HRQOL) was investigated in a subset of patients in the Fracture Prevention Trial. We sought to determine whether vertebral fracture severity was associated with HRQOL scores, and if so, to determine the effects of teriparatide (recombinant human parathyroid hormone 1-34) on vertebral fracture grades that most strongly impact HRQOL in postmenopausal women with osteoporosis. METHODS: Vertebral fracture severity was assessed by the visual semiquantitative (SQ) method. A subset of 444 patients with a baseline radiograph completed the Osteoporosis Assessment Questionnaire. Baseline HRQOL scores were modeled as a function of maximum baseline vertebral fracture grade, while controlling for age, bone mineral density, body mass index, and back pain. RESULTS: The effect of baseline vertebral fracture grade on baseline HRQOL was statistically significant, while interactions between vertebral fracture grade and the other variables were not statistically significant. SQ grade 3 (SQ3) vertebral fractures were associated with a significantly lower overall HRQOL score and with significantly lower physical function, symptoms, and emotional status dimension scores. After a median of 19 months of therapy, new or worsening SQ3 vertebral fractures occurred in 21 of 448 patients (4.7%) in the placebo group compared with 3 of 444 patients (0.7%) in the 20 mug/day teriparatide group. The risk of developing a new or worsened SQ3 vertebral fracture was reduced by 86% (P < 0.001) in patients treated with 20 mug/day teriparatide. CONCLUSION: Compared with prevalent fractures of lesser severity, SQ3 vertebral fractures were associated with reduced HRQOL. Teriparatide treatment significantly reduced the risk of new or worsening SQ3 vertebral fractures. These findings suggest, but do not directly demonstrate, a benefit of teriparatide on HRQOL.
G G Crans; S L Silverman; H K Genant; E V Glass; J H Krege
Related Documents :
935838 - Stabilization of spine fracture in paraplegic patients using a plaster cradle.
17485648 - Orthopedic outcomes of long-term daily corticosteroid treatment in duchenne muscular dy...
19371278 - Growth of infants with osteogenesis imperfecta treated with bisphosphonate.
21287148 - A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-ve...
12045538 - Technique and strategy in anterolateral thigh perforator flap surgery, based on an anal...
8968478 - Anthropometric measurements and ejection injuries.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Arthritis and rheumatism     Volume:  50     ISSN:  0004-3591     ISO Abbreviation:  Arthritis Rheum.     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-12-15     Completed Date:  2005-01-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370605     Medline TA:  Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4028-34     Citation Subset:  AIM; IM    
Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Density
Injections, Subcutaneous
Osteoporosis, Postmenopausal* / complications
Quality of Life*
Sickness Impact Profile*
Spinal Fractures* / physiopathology,  prevention & control,  psychology
Teriparatide / administration & dosage,  therapeutic use*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts f...
Next Document:  Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients...